Study of PD-1/LAG-3 signaling in T cells and development of therapeutic strategies to counteract PD-1/LAG-3 mediated resistance to cancer immunotherapy

Simple item page
dc.contributor.advisorEscors Murugarren, David
dc.contributor.advisorKochan, Grazyna
dc.contributor.authorChocarro de Erauso, Luisa
dc.contributor.departmentCiencias de la Saludes_ES
dc.contributor.departmentOsasun Zientziakeu
dc.date.accessioned2025-02-13T10:08:21Z
dc.date.issued2025
dc.date.submitted2025-02-07
dc.descriptionEl tutor de la tesis es Ignacio José Encío Martínez
dc.description.abstractA significant number of cancer patients do not benefit from PD-L1/PD-1 blockade immunotherapies. PD-1 and LAG-3 co-upregulation in T-cells is one of the major mechanisms of resistance by establishing a highly dysfunctional state in T-cells. However, how LAG-3 mechanistically triggers its downstream inhibitory signalling remains largely unknown. Likewise, how LAG-3 cooperates with PD-1 to stablish a highly dysfunctional state in T cells in cancer is also unknown. A better understanding of LAG-3 and PD-1/LAG-3 signaling will uncover the reasons behind intrinsic resistance to PD-1 blockade, develop novel treatments and improve current therapies. This PhD thesis comprises the study of PD-1/LAG-3 signaling in T-cells and the development of therapeutic strategies to counteract PD-1/LAG-3-mediated resistance to cancer immunotherapy. The results of this thesis have been organized into three chapters. In chapter 1, PD-1/LAG-3 molecular co-signaling mechanisms were identified in T-cells, uncovering CBLB ubiquitin ligases as potential targets. The combination of CBL-B inhibitors with anti-PD- 1/anti-LAG-3 immunotherapies overcame PD-1/LAG-3-mediated resistance in models of lung cancer refractory to immunotherapies. In chapter 2, the consequences of PD-1/LAG-3 cosignaling over the proteome and phosphoproteome associated to the TCR signalosome were characterized. MYC was identified as an inhibited upstream regulator of PD-1/LAG-3 proteomes and phosphoproteomes in T-cells. In chapter 3, T-cell lines expressing LAG-3 mutants in its signaling domains were engineered and analyzed by quantitative highthroughput differential proteomics and phosphoproteomics. The pathways and molecules regulated by each of LAG-3 domains and their effect on the TCR signalosome both in terms of protein expression and phosphorylation activity were characterized. These results highlighted the critical role of KIEELE and EP domains to endow LAG-3 with inhibitory functions. Overall, the results will help to identify the mechanisms of intrinsic resistance to PD-1 blockade mediated by LAG-3 co-signaling, and uncover novel therapeutic targets to counteract PD- 1/LAG-3-mediated resistance.en
dc.description.doctorateProgramPrograma de Doctorado en Ciencias de la Salud (RD 99/2011)es_ES
dc.description.doctorateProgramOsasun Zientzietako Doktoretza Programa (ED 99/2011)eu
dc.description.sponsorshipFinanciada por el Instituto de Salud Carlos III (ISCIII), co-financiada por el Fondo Europeo de Desarrollo Regional (fondos FEDER) y el Fondo Social Europeo 'Contratos PFIS: Contratos Predoctorales de Formación en Investigación en Salud' (FI21/00080) para el desarrollo de esta tesis doctoral; y por el Instituto de Salud Carlos III (ISCIII), co-financiada por El Fondo Europeo de Desarrollo Regional (fondos FEDER) y el Fondo Social Europeo 'Ayudas para la movilidad del personal investigador (Modalidad M-AES)' (MV22/00123) para realizar una estancia doctoral internacional de seis meses en University College London (UCL), optando así a la mención de Doctor Internacional.
dc.embargo.lift2030-02-07
dc.embargo.terms2030-02-07
dc.format.extent293 p.
dc.format.mimetypeapplication/pdfen
dc.identifier.doi10.48035/Tesis/2454/53370
dc.identifier.urihttps://academica-e.unavarra.es/handle/2454/53370
dc.language.isoeng
dc.relation.projectIDinfo:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2021-2023 (ISCIII)/FI21%2F00080/
dc.relation.publisherversionhttps://doi.org/10.48035/Tesis/2454/53370
dc.rights© Todos los derechos reservados
dc.rights.accessRightsinfo:eu-repo/semantics/embargoedAccess
dc.subjectPD-1en
dc.subjectLAG-3en
dc.subjectT-cellsen
dc.subjectResistanceen
dc.subjectCancer immunotherapyen
dc.titleStudy of PD-1/LAG-3 signaling in T cells and development of therapeutic strategies to counteract PD-1/LAG-3 mediated resistance to cancer immunotherapyen
dc.title.alternativeEstudio de la señalización de PD-1/LAG-3 en los linfocitos T, y desarrollo de estrategias terapéuticas para contrarrestar la resistencia a la inmunoterapia del cáncer mediada por PD-1/LAG-3es_ES
dc.typeinfo:eu-repo/semantics/doctoralThesis
dspace.entity.typePublication
relation.isAuthorOfPublicationfe5c362e-3c0c-4edb-aa2e-0de27c815ad2
relation.isAuthorOfPublication.latestForDiscoveryfe5c362e-3c0c-4edb-aa2e-0de27c815ad2

Files

Original bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
01 Tesis Chocarro.pdf
Size:
131 MB
Format:
Adobe Portable Document Format
Download

Collections

Tesis doctorales DCS - OZS Doktoretza tesiak
Tesis doctorales - Doktoretza tesiak